vimarsana.com

Latest Breaking News On - Melissal johnson - Page 2 : vimarsana.com

Dr Johnson on ABBV-011 in Small Cell Lung Cancer

Melissa L. Johnson, MD, discusses the development of the seizure-related homolog protein 6–targeting antibody-drug conjugate ABBV-011 and outcomes with this agent in patients with small cell lung cancer.

Dr Johnson on Domvanalimab, Zimberelimab, and Etrumadenant in NSCLC

Dr Johnson on Domvanalimab, Zimberelimab, and Etrumadenant in NSCLC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Dr Johnson on BL-B01D1 in Locally Advanced or Metastatic Solid Tumors

Melissa L. Johnson, MD, discusses findings from the phase 1 BL-B01D1-101 trial investigating the efficacy and safety of the EGFR- and HER3-directed antibody-drug conjugate BL-B01D1 in patients with locally advanced or metastatic solid tumors, including non–small cell lung cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.